Kronox Lab Sciences Limited, a leading manufacturer of high-purity specialty fine chemicals, is set to make a significant entry into the public market with its Initial Public Offering (IPO). Catering to a wide range of end-user industries, Kronox Lab Sciences has established itself as a trusted name in the specialty chemicals sector. The upcoming Kronox Lab Sciences IPO marks a pivotal moment in the company's journey, offering investors a unique opportunity to participate in its growth and innovation-driven future.
| Detail | Information |
|---|---|
| IPO Value | Rs. 130.15 crores |
| Total Shares Offered | 0.96 crore shares |
| IPO Subscription Period | June 3, 2024, to June 5, 2024 |
| Allotment Finalization Date | June 6, 2024 |
| Listing Date | June 10, 2024 |
| Exchanges | BSE, NSE |
| Price Band | Rs. 129 to Rs. 136 per share |
| Minimum Lot Size (Retail) | 110 shares |
Kronox Lab Sciences IPO is a book-built issue valued at Rs. 130.15 crores, with the entire offering comprising 0.96 crore shares. The subscription period for the IPO opens on June 3, 2024, and closes on June 5, 2024. The allotment is expected to be finalized on June 6, 2024, and the shares are set to list on the BSE and NSE on June 10, 2024. The price band for the IPO is Rs. 129 to Rs. 136 per share, with a minimum application lot size of 110 shares.
Pantomath Capital Advisors Pvt Ltd is the book-running lead manager, and Kfin Technologies Limited is the registrar.
Checkout the List of Upcoming IPO.
Incorporated in 2008, Kronox Lab Sciences Limited is a leading manufacturer of high-purity specialty fine chemicals catering to diverse end-user industries. Their extensive product portfolio includes over 185 items, such as phosphates, sulfates, acetates, chlorides, citrates, and nitrates.
These chemicals find applications in manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech, agrochemical formulations, personal care products, metal refineries, and animal health products.
The company serves customers in India and exports to over 20 countries, including the United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, the United Kingdom, Belgium, the UAE, and China.
Kronox Lab Sciences Limited has shown consistent financial growth over the years. As of December 31, 2023, the company reported assets of Rs. 66.96 crores, revenue of Rs. 68.44 crores, and a profit after tax of Rs. 15.47 crores. In the previous fiscal years, the revenue was Rs. 97.50 crores (2023), Rs. 83.34 crores (2022), and Rs. 63.24 crores (2021). The company had minimal borrowing, with none reported as of December 2023.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 66.96 | 54.03 | 56.79 | 37.65 |
| Revenue | 68.44 | 97.50 | 83.34 | 63.24 |
| Profit After Tax | 15.47 | 16.62 | 13.63 | 9.73 |
| Net Worth | 60.28 | 44.68 | 40.35 | 26.81 |
| Reserves and Surplus | 15.56 | 7.58 | 40.11 | 26.57 |
| Total Borrowing | - | - | 0.64 | 0.01 |
*All figures in crores
| Strengths | Weaknesses |
|---|---|
| Extensive product range with applications across diverse end-user industries | The majority of product sales are concentrated in the Pharmaceuticals and Scientific Research and Laboratory Testing industries |
| Established long-term customer relationships | Changes in demand or application processes in key industries could result in revenue and profit loss |
| Significant entry and exit barriers due to protracted customer approval cycles and stringent product standards | Failure to develop new High Purity Specialty Fine Chemicals may impact future growth and business prospects |
| Strong emphasis on Research & Development (R&D) and Quality Control | Reliance on third-party transportation and logistics providers |
A simple and smartest way to Apply in IPO online via Religare Dynami Mobile App
Retail investors need to apply for the IPO using UPI
Fill up your personal details in the form above
Fill up your DOB, PAN, email & bank account details
Upload your photo and e-sign your application via Aadhaar OTP
The price band is Rs. 129 to Rs. 136 per share.
The IPO size is Rs. 130.15 crores.
The Kronox Lab IPO lot size is 110 shares.
The minimum investment required is Rs. 14,960 for the retail category.
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved. Please note that by submitting your mobile and email on our website, you are authorizing us to Call/SMS/Whtsapp/RCS/Email you even though you may be registered under DNC. We shall Call/SMS you for a period of 12 months.
Religare Broking Limited (RBL): Registered Office: 2nd Floor, P-14, 45/90, P-Block, Connaught Place, New Delhi 110001. Board line number: 011-49871213. Fax No.: 011-49871189
Religare Broking Limited: SEBI Regn. No. INZ000174330 NSE CM, F&O, CD TM Code: 06537 Clearing Member (F&O) No. M50235; BSE CM, F&O, CD, CO TM Code: 3004 Clearing No: 3004; MSE CM, F&O, CD, TM Code: 1051 | MCX Membership No. 56560 | NCDEX Membership No. 01276 | AMFI ARN No.139809. Depository Participant: NSDL: DP ID: IN 301774 | CDSL DP ID: 30200 - SEBI Regn. No: IN-DP-385-2018. | Research Analyst Regn.No: INH100006977 | PFRDA POP registration No. 01092018 | IRDA Corporate Agent
Registration No: CA0581 | Company CIN : U65999DL2016PLC314319.
Disclaimer : Investment in securities market are subject to market risks, read all the related documents carefully before investing. RBL is a distributor of Mutual Funds / IPOs / Insurance / Bonds & NCDs. Equities, Currencies & Depository Services are offered through Religare Broking Ltd.
To remain updated on the latest market updates follow us at